Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials
Authors:
- Julie A GilmoreJGJulie A Gilmore
- Hong LiuHLHong Liu
- Uriel M HalbreichUHUriel M Halbreich
- 1 April 2003
- journal article
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 28, 69-82
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning?Psychoneuroendocrinology, 2003
- Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidonePsychoneuroendocrinology, 2003
- Multiple fixed doses of “Seroquel” (quetiapine) in patients with acute exacerbation of schizophrenia: A comparison with haloperidol and placeboBiological Psychiatry, 1997
- The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrationsSchizophrenia Research, 1997
- Spontaneous and drug‐induced movement disorders in schizophreniaActa Psychiatrica Scandinavica, 1996
- ICI 204,636, an Atypical AntipsychoticJournal of Clinical Psychopharmacology, 1996
- Olanzapine versus Placebo and HaloperidolNeuropsychopharmacology, 1996
- A STUDY OF SERUM PROLACTIN LEVELS IN SCHIZOPHRENIA: COMPARISON OF MALES AND FEMALESClinical and Experimental Pharmacology and Physiology, 1992
- The prolactin response to intravenous dextroamphetamine in normal young men and postmenopausal womenLife Sciences, 1981
- Dopaminergic factors in human prolactin regulation: Effects of neuroleptics and dopaminePsychoneuroendocrinology, 1977